[aaavl2821]

> Beijing is likely far ahead

I don't think that's true. China is doing some amazing things in biotech, and they have perhaps the best young drug discovery talent base in the world, but most VC and innovative startups are in the US for now.

Most of the Chinese VC investment has been in Series B or later stage rounds in US-based companies (some UK / EU as well). Most Series A rounds are led by US biotech VCs, and these VCs seed most of the funded startups as well. There are some large Series A rounds led by Chinese VCs (mostly Sequoia China), but not as many as by US VCs [0] -- disclosure: i created this database, it's still in alpha

There have been a few mega-rounds for Chinese biotechs recently, but it seems like a lot of those are aimed at developing Chinese versions of drugs originally developed in the west. There are exceptions of course, like Legend

Don't mean to knock China's biotech scene, but Beijing does not seem "far ahead" to me

[0] https://bio-vc-tracker.herokuapp.com/trends

[whatyoucantsay]

Thanks for the resource link. Does the data set include domestic-only Chinese investors?

[aaavl2821]

It includes some but I can't imagine it's exhaustive. I think it has most of the Chinese megarounds

If you know of any good data sources for domestic china biotech VC id love to see it